NCT01460914
- Conditions
- Cutaneous T Cell Lymphoma, Graft Versus Host Disease, Graft vs Host Disease, +11 more
- Locations
-
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
Clinical trial condition
Cutaneous T Cell Lymphoma
Explore clinical trials studying Cutaneous T Cell Lymphoma. Study availability and eligibility vary by location and protocol.
31 public trials
11 recruiting studies
Cutaneous T Cell Lymphoma trial results
NCT02192021
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- UPMC Department of Dermatology Pittsburgh, Pennsylvania, United States
NCT02576496
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Cutaneous T Cell Lymphoma, +23 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Mayo Clinic Cancer Center Jacksonville, Florida, United States
- Columbia University Medical Center New York, United States
- University Hospitals Cleveland Seidman Cancer Center Cleveland, Ohio, United States
Completed
Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL)
NCT02546440
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University Medical Center Mannheim, Germany
NCT04955340
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Covance Clinical research Unit Ltd. Leeds, United Kingdom
NCT03292406
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Galderma Investigational Site Orange, California, United States
- Galderma Investigational Site Palo Alto, California, United States
- Galderma Investigational Site Farmington, Connecticut, United States
- Galderma Investigational Site Chicago, Illinois, United States
NCT01676831
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00221039
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Rush-Presbyterian Hospital Chicago, Illinois, United States
- Boston Medical Center Boston, Massachusetts, United States
- University of Minnesota Minneapolis, Minnesota, United States
- University Hospital of Cleveland/Case Western Reserve University Cleveland, Ohio, United States
NCT01569724
- Conditions
- Cutaneous T Cell Lymphoma, Dyslipidemias, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Service de dermatologie - Hôpital de Pontchaillou Rennes, France
Completed
Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma
NCT00007345
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- University of Arkansas Little Rock, Arkansas, United States
- City of Hope National Cancer Center Duarte, California, United States
- Mercy General Hospital Sacramento, California, United States